Home › Compare › FPHHF vs ABBV
FPHHF yields 2.76% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, FPHHF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FPHHF + ABBV for your $10,000?
First Philippine Holdings Corporation engages in the power generation, real estate development, manufacturing, and construction and others business in the Philippines. It generates power through natural gas-fired, hydroelectric, geothermal, and wind and solar power plants. The company also develops residential and commercial projects; operates cinema and hotels; develops and manages industrial estate; leases, owns, acquires, and sells real and personal properties, and land; maintains and cleans buildings and other facilities; supplies water; and provides waste management and sewage treatment facilities. In addition, it offers dry-type and fluid-immersed transformers, and electronic and electrical products; and packaged substation, project, technical services, and other power solutions. Further, the company constructs power plants, transmission lines, public infrastructure, and electro-mechanical works; provides drilling and workover services for exploratory or development geothermal wells; rents and leases trucks, tractors, vans, buses, trailers, light and heavy equipment, and other motor vehicles; produces, develops, and crushes concrete aggregates and other related products; and supplies petroleum products. Additionally, it is involved in the retail and office leasing activities; hauling, trucking, and delivery of goods and materials; quarrying and the production of rocks, stones, and other related products; provision of transport for trading and distribution, and specialized medical services; oil transporting, securities transfer, medical and research, education, financing, and other activities; and construction and operation of liquid or gas pipeline. The company was formerly known as Meralco Securities Corporation and changed its name to First Philippine Holdings Corporation in September 1972. The company was incorporated in 1961 and is based in Pasig, the Philippines. First Philippine Holdings Corporation is a subsidiary of Lopez Holdings Corporation.
Full FPHHF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.